This site is intended for healthcare professionals only
LoginRegister
CDSCO Panel Directs Mankind Pharma to Conduct Phase I Trial of Sintilimab Before Phase III LaunchDelhi ITAT Deletes Rs 14.98 Cr Ad-Hoc Disallowance on Mankind Pharma's Travel Expenses
Delhi Govt Bans Genetic Sample Transfers, Tightens Abortion Pill Sales to Curb Sex-Selective PracticesDelhi Govt Bans Genetic Sample Transfers, Tightens Abortion Pill Sales to Curb Sex-Selective...
Sanofi to acquire vaccine maker Dynavax for USD 2.2 billionCDSCO Panel Recommends Updating Prescribing Information for Sanofi's Vaccine
Eli Lilly joins trillion-dollar club, fueled by weight loss drug demand boomEli Lilly Kisunla gets marketing authorization from European Commission for early symptomatic...
Delhi High CourtTrademark Clash: UNWANTED-72 Packaging Blocked, MISTAKE-72 Name Cleared by Delhi HC
Pulse Pharma Gets CDSCO Panel Nod to Manufacture, Market Aripiprazole Oral SolutionHimachal Drug Makers Unfazed by US 100% Tariff on Branded Drugs
Gujarat Medical, Dental Admissions Paused Amid AIQ Delays.PCI Bars 89 Pharmacy Colleges in Maharashtra from 2025-26 Admissions Over Regulatory Lapses
Indias generic drugs safe as Trump targets branded pharma imports: ExpertsIndia's generic drugs safe as Trump targets branded pharma imports: Experts
Khadgawan CHC Honoured with ISO Certification for Vaccine Storage StandardsCDSCO Panel Approves Novo Medi Sciences' Phase III Booster Study of PCV13 Pneumococcal Vaccine in...
Patent infringement: Factor Bioscience sues AstraZeneca, Cellectis over gene-editing technologyPatent infringement: Factor Bioscience sues AstraZeneca, Cellectis over gene-editing technology
Aurobindo Pharma China Plant incurring loss, break even expected by Q4Aurobindo Pharma arm CuraTeQ Biologics incorporates new wholly owned subsidiary in Malta
Alkem Labs Gets CDSCO Panel Nod for conducting Phase III study of Semaglutide tabletAlkem Labs transfers trade generics business to Alkem Wellness
X